Loading...

Intellectia LogoIntellectia
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. TGEN
TGEN logo

TGEN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • AI Stock Picker
  • Swing Trading
  • SwingMax Portfolio
  • QuantAI Alpha Pick
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • Financial AI Agent
  • AI Screener
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Tecogen Inc (TGEN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.190
1 Day change
-3.33%
52 Week Range
12.070
Analysis Updated At
2026/02/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Tecogen Inc. is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available. The technical indicators are mixed, with bearish moving averages and a pre-market price drop of -3.10%. While the financials show revenue growth and improved net income, the company is still operating at a loss. There are no significant positive trading signals or catalysts to suggest immediate upside potential.

Technical Analysis

The MACD is positive and expanding, indicating potential bullish momentum. However, the RSI is neutral at 60.373, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The pre-market price of $3.75 is below the pivot level of $3.689, suggesting potential downside risk. Key support levels are at $3.448 and $3.299.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
4

Positive Catalysts

  • Revenue increased by 27.58% YoY in Q3 2025, and net income improved by 129.03% YoY, showing progress in financial performance. The MACD is positive and expanding, indicating potential bullish momentum.

Neutral/Negative Catalysts

  • Gross margin dropped significantly by -31.00% YoY, and the company is still operating at a net loss. The pre-market price is down -3.10%, and moving averages are bearish. No significant trading activity from hedge funds, insiders, or Congress. No recent analyst ratings or upgrades.

Financial Performance

In Q3 2025, revenue increased by 27.58% YoY to $7,183,121. Net income improved by 129.03% YoY but remained negative at -$2,130,947. EPS improved to -0.07, up 75.00% YoY. Gross margin dropped to 30.4%, down -31.00% YoY, indicating cost pressures.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

Wall Street analysts forecast TGEN stock price to rise
1 Analyst Rating
Wall Street analysts forecast TGEN stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.300
sliders
Low
15
Averages
15
High
15
Current: 3.300
sliders
Low
15
Averages
15
High
15
Roth Capital
Chip Moore
Buy
initiated
$15
AI Analysis
2025-08-18
Reason
Roth Capital
Chip Moore
Price Target
$15
AI Analysis
2025-08-18
initiated
Buy
Reason
Roth Capital analyst Chip Moore initiated coverage of Tecogen with a Buy rating and $15 price target. The company is positioned to benefit from a \"compelling opportunity\" in the data center cooling market, the analyst tells investors in a research note. The firm sees revenue growth of 50% for Tecogen in fiscal 2026 and 74% in 2027. Tecogen should experienced an inflection to positive adjusted EBITDA later next year, Roth adds.

People Also Watch